Limiting mifepristone access, changing Title X rules and implementation of the Emergency Medical Treatment and Labor Act are ...

Robert F. Kennedy Jr. is making moves that could affect immunization uptake and policy in the U.S., while Oracle submits a ...

As hundreds of researchers, patient advocates and policymakers gather in Washington, D.C., this week for an advocacy fly-in ...

The Trump administration’s delay of what was supposed to be this week’s regularly scheduled meeting of the CDC’s vaccine ...

Virax Biolabs Group Limited (NASDAQ:VRAX) said it supports the U.S. Department of Health and Human Services’ focus on vaccine efficacy transparency, emphasizing the need for accessible information to ...

The Drug Enforcement Administration (DEA), in concert with other federal agencies, has taken various steps in the past few ...

The Supreme Court on Monday scheduled arguments for April 21 in a case that could decide the legality of the Affordable Care Act’s (ACA) requirement that insurers cover certain preventive ...

If you’re a federal worker affected by the ongoing layoffs with information relevant to keeping our coverage updated, feel ...

In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.

USDA is working to get more eggs into the supply chain in the short-term, but U.S. Agriculture Secretary Brooke Rollins says ...

Sen. Lisa Murkowski, R-Alaska, had some harsh words for the way DOGE was operating, calling the email sent to federal workers ...

The Trump Administration is calling for a report “assess[ing] the prevalence of and threat" of several drugs, including stimulants used to treat ADHD.